Envista (NYSE:NVST) Price Target Increased to $21.00 by Analysts at Stifel Nicolaus

Envista (NYSE:NVST) had its price target boosted by Stifel Nicolaus from $18.00 to $21.00 in a research note released on Wednesday morning, Benzinga reports. Stifel Nicolaus currently has a buy rating on the stock.

Several other analysts have also weighed in on NVST. JPMorgan Chase & Co. lowered shares of Envista from an “overweight” rating to a “neutral” rating and decreased their target price for the company from $23.00 to $16.00 in a research report on Thursday, August 8th. Needham & Company LLC reiterated a “hold” rating on shares of Envista in a research report on Thursday, August 8th. Piper Sandler decreased their target price on shares of Envista from $18.00 to $16.00 and set a “neutral” rating on the stock in a research report on Tuesday, July 30th. Wells Fargo & Company assumed coverage on shares of Envista in a research report on Tuesday, October 8th. They set an “equal weight” rating and a $20.00 target price on the stock. Finally, Robert W. Baird decreased their target price on shares of Envista from $19.00 to $17.00 and set a “neutral” rating on the stock in a research report on Monday, July 22nd. Three investment analysts have rated the stock with a sell rating, nine have issued a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $19.88.

Envista Stock Performance

NYSE NVST opened at $18.89 on Wednesday. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.22 and a quick ratio of 1.90. The firm has a market capitalization of $3.25 billion, a price-to-earnings ratio of -26.24 and a beta of 1.32. The company’s fifty day moving average is $18.48 and its two-hundred day moving average is $18.06. Envista has a 52-week low of $15.15 and a 52-week high of $25.64.

Envista (NYSE:NVST) last posted its quarterly earnings results on Wednesday, August 7th. The company reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.27 by ($0.16). The company had revenue of $633.10 million during the quarter, compared to analyst estimates of $646.88 million. Envista had a positive return on equity of 4.86% and a negative net margin of 52.25%. The business’s revenue for the quarter was down 4.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.43 earnings per share. Equities research analysts forecast that Envista will post 0.69 EPS for the current year.

Insider Activity at Envista

In related news, CFO Eric D. Hammes bought 24,532 shares of the company’s stock in a transaction on Monday, August 12th. The stock was bought at an average cost of $16.33 per share, with a total value of $400,607.56. Following the completion of the purchase, the chief financial officer now owns 24,532 shares in the company, valued at approximately $400,607.56. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. 1.30% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Envista

Institutional investors have recently modified their holdings of the stock. Tweedy Browne Co LLC bought a new position in shares of Envista in the first quarter worth about $21,053,000. SG Americas Securities LLC raised its stake in shares of Envista by 3,271.2% in the first quarter. SG Americas Securities LLC now owns 144,522 shares of the company’s stock worth $3,090,000 after acquiring an additional 140,235 shares during the last quarter. M&G Plc raised its stake in shares of Envista by 12.5% during the second quarter. M&G Plc now owns 306,253 shares of the company’s stock worth $5,206,000 after buying an additional 33,923 shares during the last quarter. Duality Advisers LP bought a new stake in shares of Envista during the first quarter worth approximately $1,903,000. Finally, Vanguard Group Inc. raised its stake in shares of Envista by 5.8% during the fourth quarter. Vanguard Group Inc. now owns 17,167,767 shares of the company’s stock worth $413,056,000 after buying an additional 944,596 shares during the last quarter.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.